Exact Sciences Corporation struggles with profitability due to high expenses. See why EXAS stock faces challenges despite the ...

primarily driven by Exact Sciences’ recent achievement in securing a price increase for its Cologuard Plus test. The company successfully obtained a price of approximately $592 per test through ...

Exact Sciences has enlisted Lil Jon, the poop emoji and a singing toilet for its latest Cologuard marketing push, remixing ...

TD Cowen analyst Dan Brennan raised the firm’s price target on Exact Sciences (EXAS) to $86 from $82 and keeps a Buy rating on the shares. The ...

On the heels of the premiere of its first-ever Spanish-language Cologuard campaign, Exact Sciences is doubling down on its push to raise awareness of colorectal cancer and available screening ...

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, has teamed up with multi-platinum, Grammy ...

Cologuard Plus secures 16% pricing rises from Centers for Medicare & Medicaid Services. Exact Sciences is also likely to renegotiate commercial contracts for higher pricing, which may gradually ...

Included was a final decision related to CMS pricing for Exact Sciences Corp’s (NASDAQ:EXAS) Cologuard Plus, a second-generation test that received FDA approval in October. William Blair writes ...

then the field would reach out to them and we would make sure that every provider felt that they were part of the Exact Sciences, Cologuard family from the get go. Yes, if you look at the guidance ...

On Tuesday, Wolfe Research maintained a positive outlook on Exact Sciences (NASDAQ:EXAS), reiterating an Outperform rating and a $70.00 price target. The firm's analysis indicates that the launch of ...

Based on William Blair’s estimates, this could add at least 300 basis points to Cologuard's growth rate next year, which is projected to be around 15% overall. Exact Sciences said it will ...

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, has teamed up with multi-platinum, Grammy award-winning artist Lil Jon on the “Get Low #2” campaign to ...